Keyora JointOra 5 in 1: A Multi-Target Mechanistic Strategy for Addressing the Pathophysiological Continuum of Joint Degeneration A clinically validated, multi-mechanistic formulation shown to reduce pain, stiffness, and functional limitation, delay structural degeneration, and improve mobility and quality of life in osteoarthritis, remission-phase rheumatoid arthritis, exercise-related joint strain, and NSAID-intolerant populations 0009-0007-5798-1996 DOI: 10.5281/zenodo.16939744
Undenatured Type II Collagen: as an Oral Tolerance-Inducing Immuno-modulator Restoring Treg/Th17 Balance, Suppressing Pro-Inflammatory Cytokines and Matrix-Degrading Enzymes, Stabilizing Synovial Homeostasis, and Preserving Cartilage Integrity at a Clinically Validated 40 mg/day Dose 0009-0007-5798-1996 DOI: 10.5281/zenodo.16939373
